Reference : Modeling cellular ROS defense in mitochondrial-related diseases |
Scientific congresses, symposiums and conference proceedings : Poster | |||
Life sciences : Multidisciplinary, general & others | |||
Computational Sciences | |||
http://hdl.handle.net/10993/5763 | |||
Modeling cellular ROS defense in mitochondrial-related diseases | |
English | |
Simeonidis, Vangelis ![]() | |
Kolodkin, Alexey ![]() | |
Ignatenko, Andrew ![]() | |
Sangar, Vineet [] | |
Balling, Rudi ![]() | |
Brady, Nathan [] | |
22-Jul-2013 | |
Yes | |
No | |
International | |
21st Annual International Conference on Intelligent Systemsfor Molecular Biology and 12th European Conference on Computational Biology | |
21-23 July 2013 | |
International Society for Computational Biology | |
Berlin | |
Germany | |
[en] Reactive Oxygen Species (ROS) generation is an unavoidable background process during normal cellular function. The main contributor to ROS production is the electron transport chain, which reduces oxygen to water. Some incompletely-reduced oxygen species escape and oxidize a variety of organic molecules, leading to molecular dysfunction and initiating a positive feedback loop of ever increasing active radical production. The increased concentration of ROS damages the mitochondria, therefore further elevating the rate of ROS generation. Healthy cells manage ROS enzymatically and by mitophagy of damaged mitochondria. The precise tuning of the latter mechanism is crucial for cell survival and is controlled by a ROS-induced regulatory network. We have built a set of kinetic models of varying complexity, based on the current understanding of the mechanism of cellular ROS defense. Our models allow simulation of various patho-physiological scenarios related to mitochondrial dysfunction and the failure of the system of ROS regulation in human cells. We employ the models we have constructed to simulate the effects of diseases related to mitochondrial dysfunction and excessive ROS generation, such as Parkinson’s disease, Huntington’s disease and cancer. Experimental evidence is used for model fitting, and we propose model improvements based on incorporation of single-cell experimental measurements. Finally, we discuss the perspective of integrating our kinetic models with genome-scale, constraint-based, tissue-specific models of metabolism, in order to study the effect of ROS misregulation on metabolic phenotype. | |
Luxembourg Centre for Systems Biomedicine | |
Researchers | |
http://hdl.handle.net/10993/5763 |
There is no file associated with this reference.
All documents in ORBilu are protected by a user license.